Immunotherapeutic approaches to enhance protective immunity against Candida vaginitis

Medical Mycology

Volumn 43, Issue 7, 2005, Pages 589-601

  Wozniak, Karen L ^a   Palmer, Glen ^a   Kutner, Robert ^a   Fidel Jr , Paul L ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Candida albicans; Gene therapy; Vaginitis

Indexed keywords

ADENOVIRUS VECTOR; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 12; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; HOST RESISTANCE; HUMAN; IMMUNOREGULATION; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTECTION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TH1 CELL; TISSUE DISTRIBUTION; TREATMENT FAILURE; VAGINA CANDIDIASIS; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; CANDIDA; CANDIDIASIS; CANDIDIASIS, VULVOVAGINAL; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOTHERAPY; INTERFERON TYPE II; MICE; MICE, INBRED CBA; VAGINITIS;

ADENOVIRIDAE; ANIMALIA; CANDIDA; CANDIDA ALBICANS; MURINAE;

EID: 30644468891     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780500096898     Document Type: Article

References (42)

1. Sobel, JD. (1988) Pathogenesis and epidemiology of vulvovaginal candidiasis Ann NY Acad Sci, 544, pp. 547 - 557.
2. Sobel, JD. (2002) Pathogenesis of recurrent vulvovaginal candidiasis Curr Inf Dis Rep, 4, pp. 514 - 519.
3. Sobel, JD. (1992) Pathogenesis and treatment of recurrent vulvovaginal candidiasis Clin Infect Dis, 14, pp. S148 - S153.
4. Fidel, PL, Jr and Lynch, ME and Sobel, JD. (1994) Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis Infect Immun, 62, pp. 1032 - 1038.
5. Black, CA and Eyers, FM and Russell, A and (1999) Increased severity of Candida vaginitis in BALB/c nu/nu mice versus the parent strain is not abrogated by adoptive transfer of T cell enriched lymphocytes J Reprod Immunol, 45, pp. 1 - 18.
6. Fidel, PL, Jr and Luo, W and Steele, C and (1999) Analysis of vaginal cell populations during experimental vaginal candidiasis Infect Immun, 67, pp. 3135 - 3140.
7. Wormley, FL, Jr and Chaiban, J and Fidel, PL, Jr. (2001) Cell adhesion molecule and lymphocyte activation marker expression during experimental vaginal candidiasis Infect Immun, 69, pp. 5072 - 5079.
8. Wozniak, KL and Wormley, FL, Jr and Fidel, PL, Jr. (2002) Candida-specific antibodies during experimental vaginal candidiasis in mice Infect Immun, 70, pp. 5790 - 5799.
9. Fidel, PL, Jr and Lynch, ME and Sobel, JD. (1993) Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis Infect Immun, 61, pp. 4202 - 4207.
10. Fidel, PL, Jr and Barousse, M and Espinosa, T and (2003) Local immune responsiveness following intravaginal challenge with Candida antigen in adult women at different stages of the menstrual cycle Med Mycol, 41, pp. 97 - 109.
11. Taylor, BN and Saavedra, M and Fidel, PL, Jr. (2000) Local Th1/Th2 cytokine production during experimental vaginal candidiasis Med Mycol, 38, pp. 419 - 431.
12. Wormley, FL, Jr and Steele, C and Wozniak, K and (2001) Resistance of TCR d-chain knock-out mice to experimental Candida vaginitis Infect Immun, 69, pp. 7162 - 7164.
13. Fidel, PL, Jr and Wormley, FL, Jr and Chaiban, J and (2001) Analysis of the CD4 protein on human vaginal CD4+ T cells Am J Reprod Immunol, 45, pp. 200 - 204.
14. Prellop, P and Kolls, JK.(2002) Use of gene therapy to study lung infection and immunity. In Gene Therapy in Lung Disease. (pp. 193 - 218). New York: Marcel Dekker.
15. Friedmann, T.(1999) The origins, evolution, and directions of human gene therapy. In The Development of Human Gene Therapy. (pp. 1 - 20). Cold Spring Harbor NY: Cold Spring Harbor Laboratory Press.
16. Gauldie, J and Xing, Z and Kolb, M and (2002) Use of gene transfer to study lung cytokine biology. In Gene Therapy in Lung Disease. (pp. 171 - 91). New York: Marcel Dekker.
17. Deng, JC and Tateda, K and Zeng, XY and Standiford, TJ. (2001) Transient transgenic expression of gamma interferon promotes Legionella pneumophila clearance in immunocompetent hosts Infect Immun, 69, pp. 6382 - 6390.
18. Ruan, SB and Tate, C and Lee, JJ and (2002) Local delivery of the viral interleukin-10 gene suppresses tissue inflammation in murine Pneumocystis carinii infection Infect Immun, 70, pp. 6107 - 6113.
19. Wilson, JM. (1996) Adenoviruses as gene-delivery vehicles N Engl J Med, 334, pp. 1185 - 1187.
20. Zeng, XY and Moore, TA and Newstead, MW and (2003) Intrapulmonary expression of macrophage inflammatory protein 1 alpha (CCL3) induces neutrophil and NK cell accumulation and stimulates innate immunity in murine bacterial pneumonia Infect Immun, 71, pp. 1306 - 1315.
21. Chen, GH and Reddy, RC and Newstead, MW and (2000) Intrapulmonary TNF gene therapy reverses sepsis-induced suppression of lung antibacterial host defense J Immunol, 165, pp. 6496 - 6503.
22. Moore, TA and Standiford, TJ. (2001) Cytokine immunotherapy during bacterial pneumonia: From benchtop to bedside Sem in Resp Infect, 16, pp. 27 - 37.
23. Wivel, N and Gao, G and Wilson, J.(1999) Adenovirus vectors. In The Development of Human Gene Therapy. (pp. 87 - 110). Cold Spring Harbor: Cold Spring Harbor Laboratory Press.
24. Wickham, TJ. (2000) Targeting adenovirus Gene Therapy, 7, pp. 110 - 114.
25. Romani, L and Puccetti, P and Bistoni, F.(1996) Biological role of Th cell subsets in candidiasis. In Th1 and Th2 Cells in Health and Disease. (pp. 114 - 137). Farmington CT: Karger.
26. Fidel, PL, Jr and Lynch, ME and Sobel, JD. (1993) Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis Infect Immun, 61, pp. 1990 - 1995.
27. Fidel, PL, Jr and Sobel, JD.(1999) Murine models of Candida vaginal infections. In Experimental Models in Antimicrobial Chemotherapy 2nd edn (pp. 741 - 748). London: Academic Press.
28. Noisakran, S and Carr, DJ. (2001) Topical application of the cornea post-infection with plasmid DNA encoding interferon-alpha1 but not recombinant interferon-alphaA reduces herpes simplex virus type 1-induced mortality in mice J Neuroimmunol, 121, pp. 49 - 58.
29. Noisakran, S and Campbell, IL and Carr, DJJ. (1999) Ectopic expression of DNA encoding IFN-alpha 1 in the cornea protects mice from herpes simplex virus type 1-induced encephalitis J Immunol, 162, pp. 4184 - 4190.
30. Wozniak, KL and Arribas, A and Leigh, JE and Fidel, PL, Jr. (2002) Inhibitory effects of whole and parotid saliva on immunomodulators Oral Microbiol Immunol, 17, pp. 100 - 107.
31. Saavedra, M and Taylor, B and Lukacs, NW and Fidel, PL, Jr. (1999) Local production of chemokines during experimental vaginal candidiasis Infect Immun, 67, pp. 5820 - 5829.
32. Teschendorf, C and Warrington, KH, Jr and Siemann, DW and Muzyczka, N. (2002) Comparison of the EF-1 alpha and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virus Anticancer Res, 22, pp. 3325 - 3330.
33. Kim, DW and Uetsuki, T and Kaziro, Y and Yamaguchi, N and Sugano, S. (1990) Use of the human elongation factor 1 alpha promoter as a versatile and efficient expression system GENE, 91, pp. 217 - 223.
34. Invivogen. An expression vector containing the murine Interferon-gamma open reading frame, pORF5-mIFN-g. 2002.
35. Kulkarni, AB and Ward, JM and Yaswen, L and (1995) Transforming growth factor-B1 null mice: An animal model for inflammatory disorders Am J Pathol, 146, pp. 264 - 275.
36. Katayose, D and Seth, P.(1999) Development of adenoviral vectors for gene therapy. In Adenoviruses: Basic Biology to Gene Therapy. (pp. 91 - 101). Austin TX: R. G. Landes.
37. Martino, G and Poliani, PL and Furlan, R and (2000) Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: A novel gene therapy approach J Neuroimmunol, 107, pp. 184 - 190.
38. Reiser, J and Lai, Z and Zhang, XY and Brady, RO. (2000) Development of multigene and regulated lentivirus vectors J Virol, 74, pp. 10589 - 10599.
39. Lai, Z and Han, I and Zirzow, G and (2000) Intercellular delivery of a herpes simplex virus VP22 fusion protein from cells infected with lentiviral vectors Proc Natl Acad Sci USA, 97, pp. 11297 - 11302.
40. Pardoll, D and Nabel, G.(1999) Cancer immunotherapy. In The Development of Human Gene Therapy. (pp. 427 - 457). Cold Spring Harbor NY: Cold Spring Harbor Laboratory Press.
41. Shedlock, DJ and Weiner, DB. (2000) DNA vaccination: Antigen presentation and the induction of immunity J Leuk Biol, 68, pp. 793 - 806.
42. Krieg, AM. (2001) Immune effects and mechanisms of action of CpG motifs Vaccine, 19, pp. 618 - 622.